The Venture Codex Logo

The Venture Codex

Overview

Healthcare-focused venture capital firm for bio-pharma innovations.

Founded

2004

Deals · 12mo

5

Stage focus

Series A
Series B
Series C

Geographic focus

Belgium
Denmark
France
Israel
...

Sector focus

Biotechnology
Medical Device
Pharmaceutical
Venture Capital

Investment portfolio

78rounds
NAMEDATESIZE
Abcuro
Aug 2026Participated
$66 MSeries D
Crystalys Therapeutics
Jul 2026Participated
$130 MSeries B
ADCendo
Apr 2026Participated
$76 MSeries C
Adcytherix
Oct 2025Participated
$122 MSeries A
Step Pharma
Oct 2025Participated
$44 MSeries C
Crystalys Therapeutics
Sep 2025Participated
$205 MSeries A
Abcuro
Feb 2025Participated
$200 MSeries C
Lutris Pharma
Jan 2025Led
$30 MOther Equity
Indapta Therapeutics
Dec 2024Participated
$23 MOther Equity
ADCendo
Nov 2024Participated
$135 MSeries B
Adcytherix
Jun 2024Led
$32 MSeed
ADCendo
May 2024Participated
$17 MSeries A
Abcuro
Aug 2026Participated
$66 MSeries D
Crystalys Therapeutics
Jul 2026Participated
$130 MSeries B
ADCendo
Apr 2026Participated
$76 MSeries C
Adcytherix
Oct 2025Participated
$122 MSeries A
Step Pharma
Oct 2025Participated
$44 MSeries C
Crystalys Therapeutics
Sep 2025Participated
$205 MSeries A
Abcuro
Feb 2025Participated
$200 MSeries C
Lutris Pharma
Jan 2025Led
$30 MOther Equity
Indapta Therapeutics
Dec 2024Participated
$23 MOther Equity
ADCendo
Nov 2024Participated
$135 MSeries B
Adcytherix
Jun 2024Led
$32 MSeed
ADCendo
May 2024Participated
$17 MSeries A
78
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Pontifax: 78 funding rounds are recorded in the selected participation categories.All available history.
Pontifax: 78 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed10
Series A618
Series B223
Series C+514
Other Equity27

Monthly Deal Activity

Pontifax: 78 deals are recorded across 194 months.All available history.
Pontifax: 78 deals are recorded across 194 months. All available history
MonthDeals
Sep '101
Oct '100
Nov '100
Dec '100
Jan '110
Feb '110
Mar '111
Apr '110
May '110
Jun '110
Jul '110
Aug '110
Sep '110
Oct '110
Nov '111
Dec '110
Jan '120
Feb '120
Mar '120
Apr '120
May '120
Jun '120
Jul '120
Aug '120
Sep '120
Oct '120
Nov '120
Dec '120
Jan '130
Feb '131
Mar '130
Apr '130
May '132
Jun '130
Jul '130
Aug '130
Sep '130
Oct '130
Nov '130
Dec '130
Jan '140
Feb '140
Mar '140
Apr '140
May '140
Jun '140
Jul '140
Aug '140
Sep '141
Oct '140
Nov '140
Dec '141
Jan '150
Feb '150
Mar '150
Apr '150
May '150
Jun '150
Jul '150
Aug '150
Sep '150
Oct '150
Nov '150
Dec '150
Jan '162
Feb '160
Mar '160
Apr '161
May '160
Jun '160
Jul '160
Aug '161
Sep '161
Oct '160
Nov '160
Dec '160
Jan '170
Feb '170
Mar '171
Apr '171
May '170
Jun '173
Jul '170
Aug '170
Sep '170
Oct '171
Nov '171
Dec '170
Jan '180
Feb '181
Mar '181
Apr '181
May '180
Jun '180
Jul '182
Aug '180
Sep '180
Oct '181
Nov '181
Dec '180
Jan '191
Feb '190
Mar '191
Apr '191
May '191
Jun '190
Jul '191
Aug '190
Sep '190
Oct '192
Nov '190
Dec '191
Jan '201
Feb '200
Mar '201
Apr '201
May '200
Jun '200
Jul '201
Aug '200
Sep '203
Oct '200
Nov '201
Dec '200
Jan '211
Feb '212
Mar '215
Apr '212
May '210
Jun '210
Jul '210
Aug '210
Sep '212
Oct '210
Nov '211
Dec '214
Jan '220
Feb '220
Mar '221
Apr '221
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '231
Feb '230
Mar '230
Apr '231
May '230
Jun '230
Jul '230
Aug '231
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '241
May '241
Jun '241
Jul '240
Aug '240
Sep '240
Oct '240
Nov '241
Dec '241
Jan '251
Feb '251
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '251
Oct '252
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '261
May '260
Jun '260
Jul '261
Aug '261
Sep '260
Oct '260

Sector Breakdown

Pontifax: Health & Life Sciences is the largest displayed sector by deal count (77 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Pontifax: Health & Life Sciences is the largest displayed sector by deal count (77 deals). All available history
SectorDeals
Health & Life Sciences77
Food & Agriculture4
Developer Tools3
Manufacturing3
Networks, Cloud & Communication2
Clean Energy & Sustainability2
Consumer & Lifestyle1
Travel & Hospitality1
Education & Workforce1
Space & Frontier Tech1

Deal Size Distribution

Pontifax: 78 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Pontifax: 78 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M4
$5M-$10M5
$10M-$25M12
$25M-$50M16
$50M-$100M28
$100M-$250M13
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Pontifax: United States has the largest recorded deal count among the displayed regions (35 deals).All available history.

Top 4 of 4 regions; European countries are grouped as Europe.

Pontifax: United States has the largest recorded deal count among the displayed regions (35 deals). All available history
RegionDeals
United States35
Europe27
Israel15
Taiwan1
Pontifax: 20 co-investors are shown, with OrbiMed sharing 20 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Investment Strategy

Pontifax: Led accounts for 21% and participating for 79% of round participation.All available history.
Pontifax: Led accounts for 21% and participating for 79% of round participation. All available history
CategoryDeals (count)Share (%)
Led1621%
Participating6279%
Pontifax: Single-lead accounts for 63% and co-led for 38% of lead dynamics.All available history.
Pontifax: Single-lead accounts for 63% and co-led for 38% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead1063%
Co-led638%

Team

Ran Nussbaum

Co-Founder, Managing Partner, and Partner

Tomer Kariv

Founder and CEO